A Groundbreaking Approach to Medical AI

ODELIA is a unique and groundbreaking project that harnesses the power of swarm learning to revolutionize medical AI in a privacy-preserving and democratic way. With the first open source pan-European swarm learning network, we aim to develop and validate AI algorithms for breast cancer detection in MRI screening examinations, and paving the way for numerous other clinical applications.

To ensure the project’s success and deliver its transformative results, ODELIA is structured into eight distinct work packages, each focusing on specific tasks and objectives. These work packages cover everything from creating a minimum viable product to addressing regulatory frameworks and fostering communication among stakeholders. By breaking down the project into manageable components, ODELIA is poised to make a lasting impact on the medical AI landscape and improve healthcare outcomes for patients across Europe.

ODELIA is transforming healthcare by establishing a first-of-its-kind pan-European open source swarm learning network for medical AI


Our focus is on harnessing AI for breast cancer detection in MRI screenings, serving as a model for further advancements using swarm learning. We will accelerate AI development, improve diagnostic performance, and promote generalizable solutions, while also protecting privacy and fostering collaboration, ultimately contributing to better healthcare outcomes for European patients.

Facts and figures

Coordinator: European Instititute for Biomedical Imaging Research (EIBIR)
Number of Partners: 12
Start Date: January 1, 2023
End Date: December 31, 2027
Total Funding: around € 8,691,755.00

This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101057091.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.

Skip to content